Amalgamated Bank’s Mersana Therapeutics MRSN Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-151
| Closed | -$1K | – | 3090 |
|
2025
Q1 | $1K | Hold |
151
| – | – | ﹤0.01% | 2920 |
|
2024
Q4 | $5K | Hold |
151
| – | – | ﹤0.01% | 2738 |
|
2024
Q3 | $7K | Hold |
151
| – | – | ﹤0.01% | 2629 |
|
2024
Q2 | $8K | Hold |
151
| – | – | ﹤0.01% | 2564 |
|
2024
Q1 | $17K | Sell |
151
-320
| -68% | -$36K | ﹤0.01% | 2203 |
|
2023
Q4 | $27K | Sell |
471
-36
| -7% | -$2.06K | ﹤0.01% | 2518 |
|
2023
Q3 | $16K | Hold |
507
| – | – | ﹤0.01% | 2752 |
|
2023
Q2 | $42K | Buy |
507
+131
| +35% | +$10.9K | ﹤0.01% | 2398 |
|
2023
Q1 | $39K | Sell |
376
-97
| -21% | -$10.1K | ﹤0.01% | 2405 |
|
2022
Q4 | $69K | Buy |
473
+15
| +3% | +$2.19K | ﹤0.01% | 2296 |
|
2022
Q3 | $77K | Buy |
458
+13
| +3% | +$2.19K | ﹤0.01% | 2269 |
|
2022
Q2 | $51K | Buy |
445
+13
| +3% | +$1.49K | ﹤0.01% | 2474 |
|
2022
Q1 | $43K | Sell |
432
-33
| -7% | -$3.29K | ﹤0.01% | 2547 |
|
2021
Q4 | $72K | Sell |
465
-9
| -2% | -$1.39K | ﹤0.01% | 2090 |
|
2021
Q3 | $112K | Sell |
474
-7
| -1% | -$1.65K | ﹤0.01% | 2067 |
|
2021
Q2 | $163K | Buy |
+481
| New | +$163K | ﹤0.01% | 2062 |
|
2021
Q1 | – | Sell |
-333
| Closed | -$222K | – | 1616 |
|
2020
Q4 | $222K | Buy |
+333
| New | +$222K | 0.01% | 1394 |
|